JNBA Financial Advisors’s Idexx Laboratories IDXX Stock Holding History

JNBA Financial Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.63K	Sell	5 -11	-69%	-$6.17K	﹤0.01%	693
2026 Q1	$8.99K	Buy	+16	New	+$10.3K	﹤0.01%	508
2023 Q3	–	Sell	-7	Closed	-$3.52K	–	755
2023 Q2	$3.52K	Buy	+7	New	+$3.35K	﹤0.01%	576
2022 Q1	–	Sell	-8	Closed	-$5K	–	760
2021 Q4	$5K	Sell	8 -42	-84%	-$26.4K	﹤0.01%	609
2021 Q3	$31K	Buy	+50	New	+$33.6K	﹤0.01%	351
2016 Q4	–	Sell	-300	Closed	-$34K	–	871
2016 Q3	$34K	Buy	+300	New	+$31.6K	0.01%	643

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

JNBA Financial Advisors's IDXX Position: Q2 2026 in Review

JNBA Financial Advisors reduced its Idexx Laboratories (IDXX) stake by 69% in Q2 2026, selling an estimated $6.17K and leaving 5 shares worth $2.63K. The position accounts for ﹤0.01% of the portfolio, ranked #693.

JNBA Financial Advisors first reported a position in IDXX in Q3 2016 and has held it in 6 quarters since. The position peaked at $34K in Q3 2016. 1,306 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

JNBA Financial Advisors held 5 shares of Idexx Laboratories worth $2.63K as of Q2 2026.
JNBA Financial Advisors sold 11 Idexx Laboratories shares in Q2 2026, an estimated $6.17K.
Idexx Laboratories made up ﹤0.01% of JNBA Financial Advisors's portfolio in Q2 2026, its #693 holding.
JNBA Financial Advisors first reported a position in Idexx Laboratories in Q3 2016 and has held it in 6 quarters since.
JNBA Financial Advisors's Idexx Laboratories position peaked at $34K in Q3 2016.
1,306 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on JNBA Financial Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.